Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9,133 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A randomised, double-blind, placebo-controlled, first-in-human phase I study to characterise the safety, pharmacokinetics and immunogenicity of 9MW1411 in healthy Chinese subjects.
Yang H, Wang P, Li X, Wei Q, Yu J, Wu X, Huang Y, Li R, Du W, Zeng S, Wu H, Wang S, Zhang J. Yang H, et al. Among authors: wei q. Int J Antimicrob Agents. 2024 Feb;63(2):107075. doi: 10.1016/j.ijantimicag.2023.107075. Epub 2023 Dec 27. Int J Antimicrob Agents. 2024. PMID: 38157918 Clinical Trial.
Safety, tolerability, and pharmacokinetics of a novel anti-influenza agent ZX-7101A tablets in healthy chinese participants: A first-in-human phase I clinical study.
Wu J, Wei Q, Jin Y, Cao G, Yu J, Wu X, Yang X, Li Y, Liu M, Qin X, Ai J, Wang Y, Zhang W, Zhang J. Wu J, et al. Among authors: wei q. Int J Antimicrob Agents. 2025 Jan;65(1):107381. doi: 10.1016/j.ijantimicag.2024.107381. Epub 2024 Nov 8. Int J Antimicrob Agents. 2025. PMID: 39522831 Clinical Trial.
First-in-human study to evaluate the safety, tolerability, and population pharmacokinetic/pharmacodynamic target attainment analysis of FL058 alone and in combination with meropenem in healthy subjects.
Huang Z, Yang X, Jin Y, Yu J, Cao G, Wang J, Hu Y, Dai J, Wu J, Wei Q, Tian Y, Yu S, Zhu X, Mao X, Liu W, Liang H, Zheng S, Ju Y, Wang Z, Zhang J, Wu X. Huang Z, et al. Among authors: wei q. Antimicrob Agents Chemother. 2024 Jan 10;68(1):e0133023. doi: 10.1128/aac.01330-23. Epub 2023 Dec 6. Antimicrob Agents Chemother. 2024. PMID: 38054726 Free PMC article.
Lefamulin dosing optimization using population pharmacokinetic and pharmacokinetic/pharmacodynamic assessment in Chinese patients with community-acquired bacterial pneumonia.
Bian X, Li N, Li Y, Zhu X, Yu J, Hu Y, Yang H, Wei Q, Wu X, Wang J, Cao G, Wu J, Wang Y, Zhang J. Bian X, et al. Among authors: wei q. Front Pharmacol. 2024 Oct 25;15:1456741. doi: 10.3389/fphar.2024.1456741. eCollection 2024. Front Pharmacol. 2024. PMID: 39525637 Free PMC article.
9,133 results